50,077.9
(1,383.9)
(2.84%)
27 Oct , 2026 | 04:14 PM
Open
48,797.25
Prev. Close
48,694
Market Cap.
₹0
Div Yield
0.39
PE
42.89
PB
42.89
48,749.55
50,186
Performance
One Week (%)
3.45
One Month (%)
-3.16
One Year (%)
13.74
YTD (%)
19.16
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 25,515 | 25,580 | 25,215 | 4,730 |
Glaxosmithkline Pharmaceuticals Ltd | 2,472.4 | 2,518.5 | 2,435.3 | 89,270 |
Lupin Ltd | 1,952 | 1,966.6 | 1,942.4 | 6,57,952 |
Ipca Laboratories Ltd | 1,980.8 | 1,994 | 1,938.6 | 1,89,254 |
Neuland Laboratories Ltd | 19,315 | 19,485 | 19,055 | 22,944 |
Aurobindo Pharma Ltd | 1,627.5 | 1,635 | 1,597.2 | 11,64,932 |
Natco Pharma Ltd | 794.55 | 798.85 | 785.5 | 4,33,459 |
Wockhardt Ltd | 1,884.8 | 1,893 | 1,805 | 5,24,659 |
Granules India Ltd | 830.55 | 853.5 | 817 | 7,83,735 |
Ajanta Pharma Ltd | 3,353.6 | 3,529.3 | 3,330 | 1,74,374 |
Poly Medicure Ltd | 1,470 | 1,473.5 | 1,401.5 | 32,118 |
Gland Pharma Ltd | 2,960.3 | 3,000 | 2,858.9 | 3,97,406 |
Biocon Ltd | 332.45 | 334.65 | 328 | 30,40,821 |
Alkem Laboratories Ltd | 5,078 | 5,166 | 4,963 | 1,66,281 |
Glenmark Pharmaceuticals Ltd | 2,265.7 | 2,275 | 2,214.6 | 4,83,378 |
Fortis Healthcare Ltd | 736.5 | 747.25 | 725.9 | 25,14,312 |
Syngene International Ltd | 366.2 | 372.95 | 358.75 | 8,87,125 |
Anthem Biosciences Ltd | 837.15 | 846.05 | 815.8 | 2,06,744 |
Global Health Ltd | 1,260.6 | 1,272.9 | 1,205.1 | 1,43,451 |
Krishna Institute of Medical Sciences Ltd | 697.65 | 701 | 661.55 | 4,03,492 |
Mankind Pharma Ltd | 2,502.5 | 2,529.8 | 2,352.1 | 30,30,899 |
Dr Lal Pathlabs Ltd | 1,901.8 | 1,913.9 | 1,821.3 | 2,73,785 |
Narayana Hrudayalaya Ltd | 1,713.2 | 1,723 | 1,660 | 87,732 |
Laurus Labs Ltd | 2,142 | 2,143.1 | 2,067.4 | 31,17,057 |
Sai Life Sciences Ltd | 1,486.2 | 1,490.3 | 1,435.4 | 2,30,944 |
Aster DM Quality Care Ltd | 662.8 | 673.9 | 650 | 6,93,678 |
Acutaas Chemicals Ltd | 3,793.3 | 3,900 | 3,360.5 | 47,46,620 |
Cohance Lifesciences Ltd | 479.25 | 483.7 | 460.55 | 12,27,886 |
Piramal Pharma Ltd | 198.72 | 203.37 | 194.61 | 28,73,965 |
OneSource Specialty Pharma Ltd | 1,589.8 | 1,605 | 1,384.1 | 78,03,594 |
NCDEX is expanding beyond agricultural commodities with NDEX and FINNDEX, two rule-based equity indices that will track large Indian companies and financial sector stocks. The exchange plans to introduce ETFs and mutual funds linked to the indices, followed by futures and options, subject to approvals and market readiness.
22 Oct 2026|06:45 PM
Indian stock markets ended lower for the third consecutive session on October 22, with the Sensex declining 460 points and the Nifty slipping below 22,700. Media, FMCG, IT and energy stocks led sectoral losses, while rising Brent crude prices and a sell-off across Asian markets added to investor concerns.
22 Oct 2026|04:33 PM
Sensex fell 876 points to 73,852.90 and Nifty declined 1.11% to 22,888.95 on October 19, 2026. Banking and IT stocks led losses amid earnings concerns, elevated crude oil prices and foreign investor outflows.
19 Oct 2026|06:36 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
